Seller record · Telehealth service

Teleios Health

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S5, analytical documentation: The home, FAQ and policy pages publish no certificate of analysis or equivalent lot document. 1 more criterion also fails; see the table below.

At a glance

Teleios HealthTelehealth service

6/8criteria passed

Price: Printed on its own pages before sign-up
Sells: compounded semaglutide
FDA letters: None on file

Visit Teleios Health See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A physician-led GLP-1 telehealth program with a published health-review sequence, five named pharmacy partners and a semaglutide starting-price comparison on its public website.

Operating entity Teleios Health, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Teleios Health's FAQ
S2	Prescription gating	PASS	Teleios Health's FAQ
S3	Pharmacy identification	PASS	Teleios Health's FAQ
S4	Compounding disclosure	PASS	Teleios Health's website; Teleios Health's disclaimer page
S5	Analytical documentation	FAIL	Teleios Health's website; Teleios Health's FAQ; Teleios Health's disclaimer page
S6	Business address	FAIL	Teleios Health's terms; Teleios Health's privacy policy; Teleios Health's FAQ
S7	Price disclosure	PASS	Teleios Health's website; Teleios Health's compare page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe FAQ identifies the Lion MD medical team and states that prescribing providers are licensed in their respective states. A licensed provider reviews medical history, current medications and goals.Source: Teleios Health's FAQ.

S2PASSThe published process begins with a comprehensive health questionnaire, then provider review and medication shipment only if approved.Source: Teleios Health's FAQ.

S3PASSThe pharmacy FAQ names Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx and The Pharmacy Hub as fulfillment partners.Source: Teleios Health's FAQ.

S4PASSThe home page and disclaimer state that compounded medications are not FDA-approved or evaluated by the FDA for safety, effectiveness or quality.Source: Teleios Health's website; Teleios Health's disclaimer page.

S5FAILThe home, FAQ and policy pages publish no certificate of analysis or equivalent lot document.Source: Teleios Health's website; Teleios Health's FAQ; Teleios Health's disclaimer page.

S6FAILThe public company and policy pages provide email support without a postal address for the operating business.Source: Teleios Health's terms; Teleios Health's privacy policy; Teleios Health's FAQ.

S7PASSThe home page advertises GLP-1 treatment starting at $99 a month, and the comparison page identifies the $99 figure as semaglutide. The comparison itself labels its pricing as an April observation.Source: Teleios Health's website; Teleios Health's compare page.

S8PASSNo FDA warning letter names Teleios Health or Teleios Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide.

Other sellers of the same products

Who sells semaglutide

Visit Teleios Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.